Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination.
Vono M, Taccone M, Caccin P, Gallotta M, Donvito G, Falzoni S, Palmieri E, Pallaoro M, Rappuoli R, Di Virgilio F, De Gregorio E, Montecucco C, Seubert A. Vono M, et al. Among authors: gallotta m. Proc Natl Acad Sci U S A. 2013 Dec 24;110(52):21095-100. doi: 10.1073/pnas.1319784110. Epub 2013 Dec 9. Proc Natl Acad Sci U S A. 2013. PMID: 24324152 Free PMC article.
Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate.
Kabanova A, Margarit I, Berti F, Romano MR, Grandi G, Bensi G, Chiarot E, Proietti D, Swennen E, Cappelletti E, Fontani P, Casini D, Adamo R, Pinto V, Skibinski D, Capo S, Buffi G, Gallotta M, Christ WJ, Campbell AS, Pena J, Seeberger PH, Rappuoli R, Costantino P. Kabanova A, et al. Among authors: gallotta m. Vaccine. 2010 Dec 10;29(1):104-14. doi: 10.1016/j.vaccine.2010.09.018. Epub 2010 Sep 24. Vaccine. 2010. PMID: 20870056
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.
Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G. Bensi G, et al. Among authors: gallotta m. Mol Cell Proteomics. 2012 Jun;11(6):M111.015693. doi: 10.1074/mcp.M111.015693. Epub 2012 Jan 27. Mol Cell Proteomics. 2012. PMID: 22286755 Free PMC article.
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses.
Leong WI, Ames RY, Haverkamp JM, Torres L, Kline J, Bans A, Rocha L, Gallotta M, Guiducci C, Coffman RL, Janatpour MJ. Leong WI, et al. Among authors: gallotta m. Oncotarget. 2019 Dec 31;10(68):7220-7237. doi: 10.18632/oncotarget.27322. eCollection 2019 Dec 31. Oncotarget. 2019. PMID: 31921384 Free PMC article.
Inclusive basketball training for players with intellectual disability.
Gallotta MC, Franciosi E, Giorgi M, Cossu L, Curzi D, Cerbara E, Pes G, Silvestri F, Baldari C. Gallotta MC, et al. J Sci Med Sport. 2024 Dec 26:S1440-2440(24)00625-X. doi: 10.1016/j.jsams.2024.12.015. Online ahead of print. J Sci Med Sport. 2024. PMID: 39809668 Free article.
99 results